Biohaven (BHVN) Equity Average (2021 - 2026)

Biohaven has disclosed Equity Average across 6 years of filings, most recently posting $90.8 million for Q1 2026.

• Equity Average for Q1 2026 came in at $90.8 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $90.8 million (changed N/A YoY), and the FY2025 annual result was $26.1 million, down 87.82% from the prior year.
• Equity Average came in at $90.8 million for Q1 2026 at Biohaven, up from $17.5 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of $319.5 million in Q4 2022 to a low of -$579.5 million in Q3 2024.
• The 5-year median for Equity Average is $40.4 million (2022), against an average of $11.6 million.
• Across the five-year window, Equity Average soared 567.08% in 2023 and sank 334855.49% in 2024, its largest moves.
• Biohaven's Equity Average stood at $319.5 million in 2022, then sank by 33.04% to $213.9 million in 2023, then plunged by 370.81% to -$579.4 million in 2024, then surged by 103.01% to $17.5 million in 2025, then soared by 420.08% to $90.8 million in 2026.
• The last three Equity Average figures came in at $90.8 million (Q1 2026), $17.5 million (Q4 2025), and $69.9 million (Q3 2025), per Business Quant data.